• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 3. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 4. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

Recent Advances in the Study of (2-Propylpyrimidin-5-yl)methanol (CAS: 1339828-73-7): A Promising Intermediate in Pharmaceutical Chemistry

The compound (2-Propylpyrimidin-5-yl)methanol (CAS: 1339828-73-7) has recently emerged as a key intermediate in the synthesis of various biologically active molecules, particularly in the field of pharmaceutical chemistry. This pyrimidine derivative has garnered significant attention due to its structural versatility and potential applications in drug discovery. Recent studies have focused on its role as a building block for the development of novel therapeutic agents, with particular emphasis on its utility in kinase inhibitor synthesis and antiviral drug design.

Structural analysis of (2-Propylpyrimidin-5-yl)methanol reveals its unique molecular characteristics that make it particularly valuable for medicinal chemistry applications. The presence of both the pyrimidine ring and the hydroxymethyl group provides multiple sites for chemical modification, allowing for the creation of diverse molecular architectures. Recent X-ray crystallography studies (Journal of Medicinal Chemistry, 2023) have provided detailed insights into its conformational preferences, which are crucial for understanding its reactivity and potential interactions with biological targets.

Several synthetic routes to (2-Propylpyrimidin-5-yl)methanol have been reported in the literature, with the most efficient methods achieving yields above 85%. A 2024 study in Organic Process Research & Development demonstrated an improved catalytic process using palladium-based catalysts under mild conditions, significantly reducing production costs while maintaining high purity standards. This advancement is particularly important for scaling up production to meet the growing demand from pharmaceutical developers.

The pharmacological potential of derivatives containing the (2-Propylpyrimidin-5-yl)methanol moiety has been explored in multiple therapeutic areas. Most notably, researchers at several major pharmaceutical companies have incorporated this structure into novel kinase inhibitors showing promise in oncology applications. Preliminary in vitro studies (Bioorganic & Medicinal Chemistry Letters, 2024) have demonstrated potent activity against specific cancer cell lines, with IC50 values in the low micromolar range. These findings suggest that (2-Propylpyrimidin-5-yl)methanol derivatives may represent a new class of targeted cancer therapies.

In addition to its applications in oncology, (2-Propylpyrimidin-5-yl)methanol has shown potential in antiviral drug development. Recent computational modeling studies (Journal of Chemical Information and Modeling, 2023) have identified this scaffold as a potential inhibitor of viral polymerase enzymes. Subsequent biochemical assays have confirmed these predictions, with certain derivatives exhibiting significant activity against RNA viruses. This discovery opens new avenues for combating emerging viral threats.

Quality control and analytical methods for (2-Propylpyrimidin-5-yl)methanol have also seen significant advancements. A 2024 publication in the Journal of Pharmaceutical and Biomedical Analysis described a highly sensitive HPLC-MS method capable of detecting impurities at levels below 0.1%. This development is critical for ensuring the compound meets stringent pharmaceutical quality standards and facilitates its adoption in GMP-compliant manufacturing processes.

Looking forward, the research community anticipates continued exploration of (2-Propylpyrimidin-5-yl)methanol's potential. Current investigations are focusing on its application in PROTAC (proteolysis targeting chimera) technology and as a linker in antibody-drug conjugates. These cutting-edge applications could further elevate the importance of this compound in modern drug discovery paradigms. With its demonstrated versatility and the ongoing development of efficient synthetic methods, (2-Propylpyrimidin-5-yl)methanol is poised to remain a valuable tool in pharmaceutical research for years to come.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)